이부프로펜 API 시장 규모, 점유율, 성장 분석 : 용도별, 제제 유형별, 지역별 - 업계 예측(2026-2033년)

Global Ibuprofen API Market size was valued at USD 6.46 Billion in 2024 and is poised to grow from USD 6.73 Billion in 2025 to USD 9.36 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global Ibuprofen API market is experiencing notable growth driven by increased healthcare access, a growing elderly population, and the prevalent use of generic medications. The demand for anti-inflammatory and pain relief medications, both in prescription and over-the-counter segments, is propelling market expansion. Key factors influencing this trend include a worldwide aging demographic, enhanced healthcare accessibility, and greater adoption of affordable generic alternatives. North America and Europe hold significant market shares, reflecting a stable demand for high-value APIs. However, challenges like fluctuating raw material costs and regulatory hurdles may affect operational efficiency. The outlook remains optimistic as Asia Pacific is anticipated to lead in production capacity and export volume, establishing key trends for the Ibuprofen API sector going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ibuprofen API market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ibuprofen API Market Segments Analysis

Global Ibuprofen API Market is segmented by Application, Formulation Type and region. Based on Application, the market is segmented into Pharmaceuticals, Consumer Healthcare and Animal Healthcare. Based on Formulation Type, the market is segmented into Tablets, Oral, Suspension and Topical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ibuprofen API Market

The Global Ibuprofen API market is experiencing significant growth driven by the rising demand for cost-effective pain relief and anti-inflammatory treatments. The proliferation of generic formulations, propelled by the expiration of patents and initiatives aimed at improving healthcare affordability, further strengthens market presence. Additionally, the aging population coupled with a higher prevalence of chronic pain conditions and inflammatory disorders is playing a crucial role in expanding the market's size and revenue. Together, these factors create a robust environment for the continuous development and advancement of Ibuprofen API offerings, meeting the needs of diverse consumer segments.

Restraints in the Global Ibuprofen API Market

The Global Ibuprofen API market faces significant challenges due to the volatility in the prices of essential precursors such as isobutyl benzene and acetyl chloride. These price fluctuations directly impact production costs and the overall profitability for manufacturers, particularly smaller and medium-sized enterprises. Furthermore, the market's reliance on a narrow range of suppliers poses considerable supply chain risks, leading to an unpredictable and unstable outlook. This vulnerability complicates the business environment, making it difficult for companies to maintain consistent operations and strategic planning in the face of external economic pressures.

Market Trends of the Global Ibuprofen API Market

The Global Ibuprofen API market is witnessing a significant trend towards regional diversification and near-shoring as buyers aim to mitigate supply chain risks. This shift is reshaping market dynamics, with small to mid-sized producers in the Asia-Pacific region boosting their presence and expanding production capabilities. Concurrently, there is a noticeable demand resurgence in North America and Europe, driven by the growing emphasis on security of supply. This evolving landscape not only influences sourcing strategies but also encourages greater competition among manufacturers, as stakeholders seek reliable and resilient supply chains in an increasingly volatile market environment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ibuprofen API Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
• Consumer Healthcare
• Animal Healthcare

Global Ibuprofen API Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Tablets
• Oral
• Suspension
• Topical

Global Ibuprofen API Market Size & CAGR (2026-2033)

• North America (Application, Formulation Type)
  • US
  • Canada
• Europe (Application, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Xinhua Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solara Active Pharma Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SI Group, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Granules India Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strides Pharma Science Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOCAUSE Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMS Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wanbury Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations